Want to join the conversation?
$APH narrowed its 2016 sales guidance to $6.08-6.20Bil from prior forecast of $6.04-6.20Bil. $APH also narrowed its 2016 EPS excluding one-time items outlook to $2.56-2.62 from previous estimate of $2.54-2.62. The latest sales guidance represents an increase of 9-11% over 2015 and EPS forecast represents a rise of 5-8% over 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?